Compounders Research Compare

Oruka Therapeutics, Inc.(ORKA)

Biotechnology · Menlo Park, CA

$80.25-4.13 (-4.89%)

Delayed quote: Oct 6, 2026, 12:20 PM EDT

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Menlo Park, CA

68 employees

www.orukatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Lawrence Otto Klein

View full financials

Oruka Therapeutics (ORKA) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:28:12.006Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:28:12.006Z.

Quote observation: 2026-10-06T16:25:16.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.47
Quote price: 80.315

FMP input reference: 0b6e81bfb968b053e3c664bae947515aab5c23e1d2a9854177de48c3869b2902

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ORKA Earnings Yield Metrics

EARNINGS YIELD

N/A

ORKA Competitors' Earnings Yield

Oruka Therapeutics, Inc.

Current

Market Cap

$4.84B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Dianthus Therapeutics, Inc.

Market Cap

$4.82B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Mirum Pharmaceuticals, Inc.

Market Cap

$4.86B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Definium Therapeutics, Inc.

Market Cap

$4.70B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LifeStance Health Group, Inc.

Market Cap

$4.69B

Earnings Yield

1.07%

TTM Avg

0.64%

3Y Avg

0.64%

5Y Avg

0.64%

Option Care Health, Inc.

Market Cap

$4.65B

Earnings Yield

4.28%

TTM Avg

4.92%

3Y Avg

4.57%

5Y Avg

3.88%

Erasca, Inc.

Market Cap

$5.05B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Merit Medical Systems, Inc.

Market Cap

$5.09B

Earnings Yield

2.84%

TTM Avg

2.80%

3Y Avg

2.38%

5Y Avg

2.05%

BillionToOne, Inc.

Market Cap

$4.56B

Earnings Yield

0.62%

TTM Avg

0.37%

3Y Avg

0.37%

5Y Avg

0.37%

Scholar Rock Holding Corporation

Market Cap

$5.13B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Oruka Therapeutics, Inc. (ORKA)	$4.84B	N/A	N/A	N/A	N/A
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.82B	N/A	N/A	N/A	N/A
Mirum Pharmaceuticals, Inc. (MIRM)vs ›	$4.86B	N/A	N/A	N/A	N/A
Definium Therapeutics, Inc. (DFTX)vs ›	$4.70B	N/A	N/A	N/A	N/A
LifeStance Health Group, Inc. (LFST)vs ›	$4.69B	1.07%	0.64%	0.64%	0.64%
Option Care Health, Inc. (OPCH)vs ›	$4.65B	4.28%	4.92%	4.57%	3.88%
Erasca, Inc. (ERAS)vs ›	$5.05B	N/A	N/A	N/A	N/A
Merit Medical Systems, Inc. (MMSI)vs ›	$5.09B	2.84%	2.80%	2.38%	2.05%
BillionToOne, Inc. (BLLN)vs ›	$4.56B	0.62%	0.37%	0.37%	0.37%
Scholar Rock Holding Corporation (SRRK)vs ›	$5.13B	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics